Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.
(Q38301976)
scientific article published on 08 May 2007
scientific article published on 08 May 2007
Language:
other details
| description | scientific article published on 08 May 2007 |
External Links
| (P356) |
10.1007/S00125-007-0692-2
|
| (P698) |
17486314
|
| (P5875) |
6345716
|
| (P6179) |
1051458763
|